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INTRODUCTION
Investigating the cellular and molecular mechanisms of neuropsychiatric disorders represents a significant challenge because of the inability to directly access the central nervous system for study. Although the exact pathophysiology of schizophrenia remains elusive, the general consensus is that it involves a complex interplay between multiple genetic and environmental risk factors [1] . Several lines of evidence support that schizophrenia substantially shares common biological deficits with other psychiatric conditions [2] . For example, psychosis or cognitive deficits that are prominent in patients with schizophrenia also appear in mood disorders and neurodegenerative diseases [3] .
To unravel the biological underpinnings of schizophrenia, as well as other major neuropsychiatric disorders with common deficits, several types of human biospecimens are currently being used for research, including post-mortem brains, cerebrospinal fluid, blood, fibroblasts, and genetically engineered cells, such as induced pluripotent stem (iPS) cells and induced neuronal cells. In addition to these models, the olfactory epithelium, containing mature olfactory neurons and neural progenitors, has been used in schizophrenia research. An advantage of using the olfactory epithelium is that there is no need for genetic reprogramming to obtain neurons and neural progenitors, which promises high scalability and avoids any confounds related to reprogramming in translational settings [4, 5] .
Olfactory dysfunctions are commonly observed in patients with schizophrenia, as well as in their first-degree relatives and patients with at-risk mental state. These deficits are present early in the course of the illness [6] [7] [8] [9] [10] [11] . Therefore, olfactory dysfunctions may represent one of the intrinsic traits associated with schizophrenia and have been proposed to be an endophenotype or a premorbid marker for schizophrenia [12, 13] . As several brain areas (e.g., the ventromedial temporal cortex and prefrontal cortex) mediate olfactory processing, one may hypothesize that the functional deficits may be attributed at least in part to such central abnormalities [14] . Meanwhile, as olfactory cells from the olfactory epithelium of schizophrenia patients also present particular molecular and cellular deficits [15 & ,16 & , 17, 18] , the peripheral olfactory system may also contribute to these dysfunctions. Furthermore, the molecular and cellular deficits seen in olfactory neurons and progenitors in the olfactory epithelium may represent general (or default) neural abnormalities and vulnerabilities [19] . Thus, we propose the olfactory epithelium-derived cell/tissue models as a promising surrogate system to study the molecular mechanisms implicated in schizophrenia.
NEURAL PROGENITORS IN THE OLFACTORY EPITHELIUM
The olfactory epithelium and underlying lamina propria consist of olfactory mucosa, typically located dorsally and posteriorly in the nasal cavity in mammals [20] . The olfactory epithelium is a pseudostratified epithelium that contains several types of cells, including olfactory receptor neurons (ORNs), basal cells, and sustentacular (supporting) cells [21] (Fig. 1) . ORNs are sensory neurons that project their axons onto the olfactory bulb via the olfactory nerve. Mature and immature (transitional) ORNs are located in the intermediate layer of the olfactory epithelium, and these cells are continuously replaced by neurogenesis throughout adult life [21] . Significantly, this process is regulated by the same growth factors that control neurogenesis in the central nervous system, such as the epidermal growth factor (EGF) and fibroblast growth factor (FGF2) [22] .
The basal layer, which is adjacent to the basal membrane, contains basal cells [21, 23, 24] . The olfactory epithelium retains the capacity for lifelong neurogenesis and regeneration because of the presence of these neurocompetent stem and progenitor cells [23] [24] [25] . In the mouse, it is well known that there are two types of basal cells, horizontal basal cells (HBCs) and globose basal cells (GBCs) [19] . Although it has been suggested that both HBCs and GBCs are capable of functioning as neurocompetent, broadly multipotent progenitors, HBCs are considered to be the 'reserve' stem cells of the adult olfactory epithelium. In contrast, GBCs are a more active progenitor population responsible for day-today replacement of neurons, as well as reconstituting both neuronal and nonneuronal populations of the epithelium following injury [25] . In the human, however, the composition of the basal cell population has been subject to considerable debate. The
KEY POINTS
The olfactory epithelium retains the capacity for lifelong neurogenesis and regeneration due to the presence of neural stem cells and progenitors.
Thus, there is no need for genetic reprogramming to obtain neural progenitors and mature neurons from the olfactory epithelium.
Accordingly, olfactory epithelium-derived cell/tissue models have been used as a surrogate system to study the molecular mechanisms implicated in schizophrenia.
By using olfactory epithelium-derived tissue/cell models, alterations in neurodevelopment, stress response, and gene/protein expression regulatory pathways have been recently found in patients with schizophrenia. OLFACTORY EPITHELIUM-DERIVED TISSUE/CELL MODELS Thus far, multiple protocols have been developed to model the pathophysiology of brain disorders by using olfactory epithelium-derived tissue/cells [4, 5, 19, 26, 27] (Table 1 ). However, a systematic comparison of observations obtained from different protocols for the olfactory epithelium has not been made. To organize these findings, we categorize olfactory epithelium-derived tissue/cell models into two groups in this review: olfactory neurospheres and their derived cells; and nonneurosphere approach, including other olfactory epitheliumderived cultured cells and tissues. Note, olfactory neurospheres are defined as cellular spheres formed from olfactory stem/progenitor cells in olfactory mucosa/epithelium cultures [28, 29] .
Olfactory neurospheres and their derived cells
Neural stem/progenitor cells from the forebrain typically grow in vitro as spheres and are used as a surrogate cell type to study neural stem/progenitor cells [30] . Similarly, culture techniques have been established for human olfactory epithelium to generate populations of mitotically active neural progenitors that form neurospheres [28, 29, 31] . The resulting olfactory neurospheres and their derived cells are multipotent and capable of self-renewal, and can be differentiated into neurons and glia [29, 32] . Although there are several protocols to obtain neurospheres from a nasal biopsy, a protocol from Mackay-Sim's group has been most intensively used in schizophrenia research [15 & ,33-36] . Briefly, olfactory mucosa biopsies including the olfactory epithelium and lamina propria are dissociated and grown for 3 days in Dulbecco's modified Eagles medium (DMEM)/F12 supplemented with 10% fetal bovine serum (FBS). Then, the primary cultures are passaged into flasks coated with poly-L-lysine and incubated in DMEM/F12 containing EGF (50 ng/ml) and FGF2 (25 ng/ml). Once cell clusters attach to the culture dish, some cells float from the surface to form neurospheres. The free-floating neurospheres are then harvested, dissociated, and expanded in DMEM/F12 with 10% FBS (neurosphere-derived cells) [15 & ,33-36] . Human olfactory neurosphere cultures express cell markers including CD105 (mesenchymal stem cell marker), CD73 (mesenchymal stem cell marker), organic cation/carnitine transporter 4 (embryonic stem cell marker), Nestin (neural stem cell marker), and b-tubulin III (immature neuron marker) [34] . Importantly, their gene expression profiles are stable between passages 7 through 25, and at more than 100 days in vitro [34] . Note, the olfactory lamina propria dissected from the olfactory mucosa also forms spheres and gives rise to bone cells and neurons. Indeed, olfactory lamina propria stem cells share membrane markers with bone marrow stem cells and are named, olfactory ectomesenchymal stem cells [37] . Other groups have demonstrated that neurosphere-forming cells derived from the olfactory epithelium can be directed towards neuronal lineage restriction by sonic hedgehog, forskolin, and retinoic acid [38] , and that human olfactory spheres express oligodendrocyte progenitor cell markers [31] .
Nonneurosphere approach
Nasal biopsies can be also used to establish dissociated, adherent cultures without sphere formation, or explant cultures [17, [39] [40] [41] . One protocol for dissociated cultures can purify homogenous, b-tubulin III-positive cell populations through replating process to remove possible contamination by unwanted cell types. Such olfactory cells have shown similar gene expression profiles to stem cells and brain tissues, but not blood cells [42] .
The whole or dissected olfactory epithelium tissue can also be used to address anatomical and molecular questions related to brain diseases [11, 18, 43] , but it is difficult to utilize the olfactory epithelium tissue models for functional assays [4] . However, the tissue models can address state changes associated with disease [5] . To selectively enrich the neural population, the neural layer can be isolated from the olfactory epithelium tissue by combining nasal biopsies with laser-capture microdissection (LCM) [43, 44] .
FINDINGS FROM OLFACTORY EPITHELIUM-DERIVED TISSUE/CELL MODELS OBTAINED FROM SCHIZOPHRENIA PATIENTS

Olfactory neurospheres and their derived cells
Using microarray gene expression profiling, olfactory neurosphere-derived cells from nine medicated schizophrenia patients showed dysregulation of genes involved in brain development, specifically in focal adhesion, axonal guidance, and receptormediated signalling, relative to cells from 14 healthy Increased levels of the oxidative stress markers, heme oxygenase-1, hydroxynonenal pyrrole, and N-carboxymethyl lysine Ghanbari et al. [60] Tissue Increased neurofilament immunoreactivity and abnormal neuronal structure that are correlated with brain pathology Talamo et al. [55] Presence of tau-reactive and ubiquitin-reactive dystrophic neurites in the lamina propria Tabaton et al. [56] Increased immunoreactivity for manganese and copper-zinc superoxide dismutase Kulkarni-Narla et al. [58] Increased immunoreactivity for 3-nitrotyrosine in olfactory receptor neurons and CD68 in macrophages Getchell et al. [59] Expression of beta-amyloid and paired helical filament-tau in olfactory epithelium significantly correlated with brain pathology
Arnold et al. [54] Parkinson's disease Olfactory neurospheres and their derived cells Disease-specific alterations in gene and protein expression, including dysregulation of those involved in mitochondrial function, oxidative stress, and xenobiotic metabolism Matigian et al. [34] Reduction in glutathione levels and MTS metabolism that is restored by activation of the nuclear factor E2-related factor 2 (NRF2) pathway
Cook et al. [61] MTS, 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium.
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www.co-psychiatry.comcontrols. Importantly, five of the identified pathways had already been implicated in schizophrenia pathophysiology (reelin signalling in neurons, vitamin D receptor and retinoid X receptor activation, ErbB signalling, IL-8 signalling, and glutathione metabolism) [34] . A discovery-based proteomics approach using olfactory neurosphere-derived cells from the same nine medicated schizophrenia patients and nine of the above 14 controls demonstrated that several proteins were differentially expressed in schizophrenia relative to control cells, particularly those involved in the eukaryotic initiation factor 2/4 (eIF2/4) and mechanistic target of rapamycin (mTOR) pathways. Schizophrenia cells also showed decreased expression of 17 ribosomal proteins, which was associated with reduced rate of protein synthesis, as well as dysregulation of cytoskeletal, mitochondrial, and calcium-binding proteins compared with control cells [15 & ]. Significantly, dysregulation of the eIF2 and mTOR pathways was also reported in an iPS cell model derived from schizophrenia patients [45] .
Olfactory neurosphere-derived cells from these nine schizophrenia patients showed increased cell proliferation within 96 h and cell cycle entry within 30 h compared with the nine control cell lines. Also, cell cycle phases were advanced by 2 h, and the cell cycle period was 2 h shorter in patients' cells compared with control cells. Significantly, these cell cycle phenotypes were associated with increased expression of cyclin proteins D1 (CCND1), E (CCNE), and A2 (CCNA2) in schizophrenia cells. Thus, dysregulated cell cycle dynamics may alter the temporal and spatial cascade of brain development and contribute to an altered neurodevelopmental trajectory in schizophrenia [35] .
Finally, altered focal adhesion dynamics were reported in these cells. The focal adhesion kinase (FAK) signalling pathway plays a major role in regulating the formation of focal adhesions and actin stress fibres and is involved in neuronal migration during brain development [36] . Integrins are also involved in adhesion to the extracellular matrix during cell migration [36] , and schizophrenia olfactory neurosphere-derived cells showed increased expression of integrin subunit alpha 8 relative to control cells [34] . Schizophrenia cells showed reduced phosphorylation of FAK at tyrosine-397 (Y397-pFAK) compared with control cells, and this observation was associated with diminished cell adhesion, as well as increased motility that was reduced to control levels by using antibodies to block integrins a8 and b1. Unexpectedly, reducing Y397-pFAK with an FAK inhibitor also decreased the patient cells' motility to control levels. These paradoxical results were discussed as a future topic in this report [36] . Furthermore, patient cells had fewer and smaller component proteins of focal adhesion protein complexes that disassembled faster than in control cells. Thus, FAK signalling is a potential candidate pathway that may affect neuronal migration in the developing brain in schizophrenia [36] .
These findings from schizophrenia olfactory neurosphere-derived cells suggest alterations in neurodevelopmental processes that are involved in the pathophysiology of this disease. However, it is important to consider that a limited number of research groups have used this cell model in a small number of patients to investigate the pathophysiology of schizophrenia. More studies using this cell model from different groups are warranted to confirm these observations.
Nonneurosphere approach
A study using olfactory cells purified through the replating technique observed increased expression of miR-382 in schizophrenia relative to control cells. miR-382 was also previously shown to be increased in autopsied brains of schizophrenia patients [46] . Furthermore, these schizophrenia cells showed altered levels of histone methylation in several gene groups involved in cellular protection against oxidative stress, suggesting a potential role of oxidative stress in the pathophysiology of schizophrenia [17] . Cultured cells established via nasal brush swab showed altered microtubular organization, together with decreased function of L-type Ca 2þ channels in patients with schizophrenia relative to controls [47] . An olfactory epithelium explant (nondissociated) culture from schizophrenia patients showed increased stability of microtubules and a greater percentage of cells with intact microtubules [40] , as well as a higher ratio of mitotic cells to dying and quiescent cells [41, 48] . In addition, this olfactory epithelium explant culture showed differential expression in genes implicated in nonselective vesicular transport, DNA recombination, RNA splicing, and cell proliferation between schizophrenia patients and healthy subjects [48] .
Olfactory tissue has provided insights into the neurodevelopmental aspects of the disease. For example, by using neural layers from biopsied olfactory epithelium enriched by LCM, the SMAD pathway was found to be downregulated and potentially associated with cognitive deficits in schizophrenia [16 & ]. A significant decrease in the density of p75-NGFR-positive basal cells in schizophrenia olfactory epithelium nasal biopsies was also observed, suggesting dysregulation in the development of ORNs [11] . A dysregulation of olfactory epithelium neural lineage was also reported in olfactory epithelium tissue obtained at autopsy, as observed in the abnormal densities and ratios of olfactory epithelium neurons at different developmental stages in schizophrenia samples. It was further suggested that a lack of trophic support from axonal targets in the olfactory bulb or deficits in intrinsic factors controlling differentiation might contribute to these observations [18] . Finally, abnormalities in chondroitin sulfate proteoglycans expression resulting in disruption of ORNs' axonal outgrowth and guidance were also reported in post-mortem olfactory epithelium tissue from schizophrenia patients [49] .
LESSONS FROM OTHER BRAIN CONDITIONS (Table 1) Other neurodevelopmental disorders At the molecular level, it was found that molybdenum cofactor sulfurase, involved in purine metabolism, was downregulated in nasal olfactory stem cells isolated from nasal biopsies of adults with autism [50 & ]. In Rett syndrome, which is due to a mutation in the methyl-CpG-binding protein 2 (MECP2) gene, biopsies of nasal epithelium containing ORNs revealed several abnormalities compared with controls, including dysmorphic neurons, as well as an increased ratio of immature to mature neurons [51] . Finally, continuous cell lines of olfactory neuroblasts were used to study the fragile X mental retardation 1 mutation in patients with fragile X syndrome [52] .
Bipolar disorder
Some in vitro abnormalities were observed in olfactory epithelium-derived neural cells from bipolar disorder patients, such as alterations in intracellular calcium signalling in biopsy-derived ORNs [53] , and a higher ratio of dying to live cells in olfactory neuroepithelial cultures relative to that in control cultures [48] . Moreover, in the latter study, gene expression profiling in olfactory neuroepithelial cultures revealed that 210 genes were differentially expressed between bipolar disorder patients and controls, with a decreased expression of five genes involved in or related to the phosphatidylinositol signalling [48] . Finally, a platform using nasal biopsies combined with LCM showed the effect of lithium treatment on glycogen synthase kinase-3 beta gene expression [44] .
Neurodegenerative diseases
At the histological level, several studies reported the presence of typical signs of Alzheimer's disease in the post-mortem olfactory mucosa [54, 55] and cultured olfactory tissue [56, 57] , including increased staining for tau, amyloid precursor protein, amyloid-b, apolipoprotein E, neurofilaments, as well as signs of oxidative stress [58] [59] [60] . The use of olfactory neurospheres led to interesting findings about the pathophysiology of Parkinson's disease, including the potential implication of the nuclear factor E2-related factor 2 signalling pathway [61] , as well as dysregulation of pathways implicated in oxidative stress, mitochondrial function, and xenobiotic metabolism [34] .
CONCLUSION
As the olfactory epithelium retains the capacity for lifelong neurogenesis and regeneration due to the presence of neural stem cells and progenitors, confounds related to genetic reprogramming when establishing iPS cells can be bypassed by using olfactory epithelium-derived neural cells. Furthermore, olfactory epithelium-derived neural cells can be collected longitudinally from human patients in a relatively noninvasive manner. Based on these valuable advantages of the olfactory epithelium, olfactory epithelium-derived cell/tissue models have been utilized to uncover neural signatures relevant to the disorder of schizophrenia and other brain disorders in living patients as a powerful complementary tool to iPS cell-derived models. This discovery-based proteomics approach demonstrated that proteins involved in the eIF2/4 pathway and mechanistic target of rapamycin signalling were the most differentially expressed in olfactory neurosphere-derived cells between schizophrenia and controls. A decreased expression of 17 ribosomal proteins was also observed in schizophrenia patients, which was associated with a reduction in the rate of protein synthesis in schizophrenia. These observations suggest an alteration in protein expression regulation in olfactory neurosphere-derived cells from schizophrenia patients, which may contribute to the aberrant neurodevelopmental processes of the disorder. 16.
